ECS Botanics Holdings
Follow
Get notifications in MyBN when activity occurs.
Industry Lists
Public Companies - non WAECS Botanics is an Industrial Hemp company with its main project and operations currently based in Tasmania Australia.
ECS aims to take advantage of expected growth in the cannabis industry (particularly industrial hemp), locally and globally, by supplying and manufacturing a range of high quality wholesale and retail based products across a range of industry sectors including initially food and nutraceuticals.
ECS' focus is on industrial hemp with, and subject to receiving the relevant medicinal cannabis licenses from the Australian Office of Drug Control, will establish a medicinal cannabis component of the business.
ECS listed on the ASX in July 2019, via the reverse takeover of WA-based Axxis Technology.
Contact Details
Suite 2, Level 15, 3 Spring Street, SYDNEY NSW 2000
0407 777 584
Lists and Charts
Share price
Closing price for the last 90 trading days
Powered by Morningstar ®
Total Shareholder Return as at 31/10/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1260th | ECS Botanics Holdings | -29% | -18% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | ECS Botanics Holdings | $22.6m |
1334 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Company Activity
| NEW ROLE: Arthur Sun, | 01 Nov 2024 |
| NEW ROLE: Rachel Swift, Non-Executive Director | 07 Oct 2024 |
| ECM DEAL: New deal has been added | 19 Jul 2021 |
| M&A DEAL: New deal has been added | 14 Jul 2021 |
| ECM DEAL: New deal has been added | 09 Feb 2021 |
| ECM DEAL: New deal has been added | 02 Feb 2021 |
| NEWS: Tagged in Corporate finance deals Feb 11 to 15 2019 | 18 Jan 2021 |
| NEWS: Tagged in Corporate finance deals Jun 17 to 21 2019 | 18 Jan 2021 |
| NEW ROLE: Jeremy King, Non-Executive Director, Chair | 03 Nov 2020 |
